Seretide
Seretide is a combination preventer inhaler containing two active ingredients: salmeterol (a long-acting beta-2 agonist bronchodilator) and fluticasone propionate (a corticosteroid). Salmeterol helps to keep the airways open, while fluticasone reduces inflammation, swelling, and irritation in the lungs. It is used for regular, daily maintenance therapy and is not intended to relieve sudden, acute asthma attacks.
Dosage by Body Weight
Inhale the prescribed dose regularly, typically twice daily (morning and evening), even when free of symptoms. Always rinse your mouth thoroughly with water and spit it out after each use to reduce the risk of oral thrush and hoarseness. Do not stop using this medicine abruptly without consulting your doctor. Keep a separate fast-acting rescue inhaler (like Salbutamol) with you at all times for sudden breathing difficulties.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy in infants have not been established. Not for use in this weight range.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy in infants have not been established. Not for use in this weight range.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Not applicable
- Tracking Notes
- Seretide is generally not recommended for children under 4 years of age. Use only under direct specialist supervision.
- Body Weight
- 11-15 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Dosing for children (4 years and older) is based on clinical severity and age, not body weight. If prescribed, low-dose formulations (e.g., 50 mcg fluticasone / 25 mcg salmeterol) are utilized.
- Body Weight
- 16-20 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- For pediatric patients matching this typical age range (4 years and older), dosing depends strictly on asthma severity and is determined by a physician, not by weight.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Not applicable | Safety and efficacy in infants have not been established. Not for use in this weight range. |
| 5-7 kg | Not recommended | Not applicable | Safety and efficacy in infants have not been established. Not for use in this weight range. |
| 8-10 kg | Not recommended | Not applicable | Seretide is generally not recommended for children under 4 years of age. Use only under direct specialist supervision. |
| 11-15 kg | Not routine | Use only if prescribed | Dosing for children (4 years and older) is based on clinical severity and age, not body weight. If prescribed, low-dose formulations (e.g., 50 mcg fluticasone / 25 mcg salmeterol) are utilized. |
| 16-20 kg | Not routine | Use only if prescribed | For pediatric patients matching this typical age range (4 years and older), dosing depends strictly on asthma severity and is determined by a physician, not by weight. |
Formulation
Purpose
Long-term management and prevention of asthma symptoms, and symptomatic treatment of patients with Chronic Obstructive Pulmonary Disease (COPD).
Generic Name
Salmeterol + Fluticasone propionateScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.